NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $19.88 +0.48 (+2.45%) As of 11:43 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Fortrea Stock (NASDAQ:FTRE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fortrea alerts:Sign Up Key Stats Today's Range$19.09▼$19.9250-Day Range$16.79▼$20.7052-Week Range$8.55▼$21.39Volume173,388 shsAverage Volume1.49 million shsMarket Capitalization$1.89 billionP/E RatioN/ADividend YieldN/APrice Target$22.00Consensus RatingHold Company Overview Fortrea Holdings Inc. is a global contract research organization (CRO) that provides services to pharmaceutical, biotechnology and medical device companies. The company supports the development and commercialization of healthcare products across a range of therapeutic areas. Its services include clinical trial management, study design, patient recruitment and engagement, data management, biostatistics, regulatory support, medical affairs and post-approval services. Fortrea also provides technology-enabled and decentralized clinical trial solutions intended to help sponsors conduct research across traditional and remote settings. Fortrea serves customers internationally, with operations and clinical trial capabilities spanning North America, Europe, Asia-Pacific and other global markets. The company was established in 2023 following the separation of Labcorp’s clinical development business and is headquartered in Durham, North Carolina.AI Generated. May Contain Errors. Read More Fortrea Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks62nd Percentile Overall ScoreFTRE MarketRank™: Fortrea scored higher than 62% of companies evaluated by MarketBeat, and ranked 370th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 5 buy ratings, 6 hold ratings, and 1 sell rating.Upside PotentialFortrea has a consensus price target of $22.00, representing about 13.4% upside from its current price of $19.40.Amount of Analyst CoverageFortrea has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth24.71% Earnings GrowthEarnings for Fortrea are expected to grow by 24.71% in the coming year, from $0.85 to $1.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -21.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -21.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 0.48. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 3.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.29% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 10.2, which indicates bearish sentiment.Change versus previous monthShort interest in Fortrea has recently increased by 5.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.50 News SentimentFortrea has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Fortrea this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for FTRE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Fortrea to their MarketBeat watchlist in the last 30 days. Company Ownership0.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,917,635.00 in company stock.Percentage Held by Insiders0.73% of the stock of Fortrea is held by insiders.Percentage Held by InstitutionsFortrea has minimal institutional ownership at this time.Read more about Fortrea's insider trading history. Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTRE Stock News HeadlinesContrasting Bullfrog AI (NASDAQ:BFRG) and Fortrea (NASDAQ:FTRE)October 2 at 4:59 AM | americanbankingnews.comFortrea Holdings Inc. (NASDAQ:FTRE) Stock Has Consensus Target Price of $22.00 According to BrokeragesOctober 1 at 4:29 AM | americanbankingnews.comElon will prove them wrong againElon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no driver in major U.S. cities. Veteran tech investor James Altucher says Musk is applying the same playbook to a new project he calls his infinite money glitch, expected to launch October 21. Altucher, who has tracked tech breakthroughs for nearly four decades, calls this the biggest one he has ever covered.October 2 at 1:00 AM | Paradigm Press (Ad)Fortrea Names Carrie Russell Chief Accounting OfficerSeptember 30 at 4:51 PM | tipranks.com3 Healthcare Stocks That Concern UsSeptember 30 at 7:19 AM | finance.yahoo.comFortrea (FTRE) Stock Could Be 46% Undervalued As Deal Questions BuildSeptember 26, 2026 | finance.yahoo.com2 small-cap stocks to research further and 1 facing challengesSeptember 23, 2026 | msn.com2 of Wall Street’s favorite stocks to target this week and 1 facing challengesSeptember 16, 2026 | msn.comSee More Headlines FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $17.25 at the beginning of the year. Since then, FTRE stock has increased by 12.5% and is now trading at $19.40. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) released its earnings results on Wednesday, July, 29th. The company reported $0.23 EPS for the quarter, topping analysts' consensus estimates of $0.18 by $0.05. The firm earned $678.20 million during the quarter, compared to analysts' expectations of $647.57 million. Fortrea had a negative net margin of 3.18% and a positive trailing twelve-month return on equity of 10.72%. Read the conference call transcript. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fortrea own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fortrea investors own include AUO (AUOTY), Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings7/29/2026Today10/02/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 FTRE's financial health is in the Green zone, according to TradeSmith. FTRE has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:FTRE CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees14,000Year Founded2023Price Target and Rating Average Price Target for Fortrea$22.00 High Price Target$26.00 Low Price Target$16.00 Potential Upside/Downside+11.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.91) Trailing P/E RatioN/A Forward P/E Ratio23.27 P/E Growth0.48Net Income-$986.20 million Net Margins-3.18% Pretax Margin-2.91% Return on Equity10.72% Return on Assets2.17% Debt Debt-to-Equity Ratio1.98 Current Ratio0.96 Quick Ratio0.96 Sales & Book Value Annual Sales$2.72 billion Price / Sales0.69 Cash Flow$9.84 per share Price / Cash Flow2.01 Book Value$6.10 per share Price / Book3.24Miscellaneous Outstanding Shares95,100,000Free Float94,406,000Market Cap$1.88 billion OptionableOptionable Beta1.92 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:FTRE) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe SEC Just Opened The Floodgates…The SEC removed the 25 year old Pattern Day Trader rule in June 2026, cutting the minimum to open a trading ac...StocksToTrade | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
